Evidence map›Paper›PMID 23028323›Full record

ArticlePLoS pathogens2012

A novel rhabdovirus associated with acute hemorrhagic fever in central Africa.

Gilda Grard, Joseph N Fair, Deanna Lee, Elizabeth Slikas, Imke Steffen, Jean-Jacques Muyembe, Taylor Sittler, Narayanan Veeraraghavan, J Graham Ruby, Chunlin Wang and 12 more

Erratum issuedAbstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 132 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Use of Next-Generation Sequencing in Personalized Medicine.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Blood Virome: A new frontier in biomedical science.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Review
  17. Biographical Feature: Charles Y. Chiu, M.D., Ph.D.Journal of clinical microbiology · 2024
    Article
  18. Article
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Gilda GrardViral Emergent Diseases unit, Centre International de Recherches Médicales de Franceville, Franceville, Gabon.
Joseph N Fair
Deanna Lee
Elizabeth Slikas
Imke Steffen
Jean-Jacques Muyembe
Taylor Sittler
Narayanan Veeraraghavan
J Graham Ruby
Chunlin Wang
Maria Makuwa
Prime Mulembakani
Robert B Tesh
Jonna Mazet
Anne W Rimoin
Travis Taylor
Bradley S Schneider
Graham Simmons
Eric Delwart
Nathan D Wolfe
Charles Y Chiu
Eric M Leroy

Funding

Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious AgentsR01HL105704 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2011 to 2020
$5.9M
Metagenomic detection of emerging viruses in the blood supplyR01HL105770 · NHLBI · VITALANT · PI DELWART, ERIC L · 2011 to 2015
$2.4M
Metagenomic analysis of the human viromeR01HL083254 · NHLBI · VITALANT · PI DELWART, ERIC L · 2007 to 2010
$1.6M
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense PathogensR56AI089532 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN, PATTERSON, JEAN L. · 2010 to 2010
$888k
NHLBI NIH HHS R01 HL083254NHLBI NIH HHS R01-HL083254NHLBI NIH HHS R01 HL105704NHLBI NIH HHS R01-HL105704NHLBI NIH HHS R01 HL105770NHLBI NIH HHS R01-HL105770NIAID NIH HHS HHSN272201000040INIAID NIH HHS R56 AI089532NIAID NIH HHS R56-AI089532
6 · The paper itself

Abstract

Deep sequencing was used to discover a novel rhabdovirus (Bas-Congo virus, or BASV) associated with a 2009 outbreak of 3 human cases of acute hemorrhagic fever in Mangala village, Democratic Republic of Congo (DRC), Africa. The cases, presenting over a 3-week period, were characterized by abrupt disease onset, high fever, mucosal hemorrhage, and, in two patients, death within 3 days. BASV was detected in an acute serum sample from the lone survivor at a concentration of 1.09 × 10(6) RNA copies/mL, and 98.2% of the genome was subsequently de novo assembled from ≈ 140 million sequence reads. Phylogenetic analysis revealed that BASV is highly divergent and shares less than 34% amino acid identity with any other rhabdovirus. High convalescent neutralizing antibody titers of >1:1000 were detected in the survivor and an asymptomatic nurse directly caring for him, both of whom were health care workers, suggesting the potential for human-to-human transmission of BASV. The natural animal reservoir host or arthropod vector and precise mode of transmission for the virus remain unclear. BASV is an emerging human pathogen associated with acute hemorrhagic fever in Africa.

Indexed as

RhabdoviridaeAdolescentAdultAnimalsAntibodies, ViralDemocratic Republic of the CongoDisease OutbreaksFemaleGenome, ViralHemorrhagic Fevers, ViralHigh-Throughput Nucleotide SequencingHumansMaleMiceMolecular Sequence DataPhylogenyAntibodies, Viral

Identifiers

PMID23028323
PMCPMC3460624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.